Email updates

Keep up to date with the latest news and content from Molecular Cancer and BioMed Central.

Open Access Open Badges Short communication

Is cumulative frequency of mitochondrial DNA variants a biomarker for colorectal tumor progression?

Felix O Aikhionbare1*, Masood Khan2, Delicia Carey3, Joel Okoli4 and Rodney Go2

Author Affiliations

1 Department of Medicine, Morehouse School of Medicine, Atlanta, GA 30310, USA

2 School of Public Health, University of Alabama, Birmingham, AL 35294, USA

3 Comprehensive Cancer Center, University of Alabama, Birmingham AL 35294, USA

4 Department of Surgery, Morehouse School of Medicine, Atlanta GA 30310, USA

For all author emails, please log on.

Molecular Cancer 2004, 3:30  doi:10.1186/1476-4598-3-30

Published: 13 October 2004


To examine the relationship between mitochondrial DNA (mtDNA) alterations and colorectal tumorigenesis, we used high-resolution restriction endonucleases and sequencing to assess the mitochondrial genome from three histologic subtypes of colorectal adenomas (tubular = 8; tubulovillous = 9; and villous = 8), colorectal cancer (CRC) tissues = 27, and their matched surrounding normal tissue (MSNT) = 52. The mitochondrial genomes were amplified using 9 pairs of overlapping primers and systematically analyzed by means of high-resolution analysis. DNA fragments showing a shift in banding patterns between the three adenomas, CRC, in comparison to the MSNT were sequenced to identify the mtDNA alterations. A total of thirty-eight germ-line mtDNA variants were observed in this study. Twenty-two of the thirty-eight were identified as mutations and 59% (13 of 22) were silent mutations and one was a 1-bp insertion. Sixteen of thirty-eight were distinct SNPs in flanking regions of the restriction sites and, 6 of the 16 (37%) SNPs were not previously reported. Most of these mutations/SNPs were homoplasmic and distributed in various regions of mitochondrial genes including the 16S and 12S rRNA. Based on our results, mtDNA germline variants increased in prevalence with adenoma CRC progression. To the best of our knowledge, this is the first report to show an increased prevalence of mitochondrial gene variants in CRC tumorigenesis.